Home Compare AFX.DE vs SOLV
Stock Comparison · Industry comparison · Medical Instruments & Supplies

Carl Zeiss Meditec vs Solventum: Which Stock Looks Stronger in 2026?

Solventum holds the cleaner structural position, with the lead spread across profitability and stability. Carl Zeiss Meditec does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across profitability and stability, rather than sitting in one isolated gap. Solventum Corporation leads by 23 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Medical Instruments & Supplies

This comparison is based on industry proximity, not on functional trajectory similarity. AFX.DE and SOLV share the same industry classification.

For a similarity-based comparison, see how Carl Zeiss Meditec and Solventum each position within their functional peer groups in AssetNext.

Peer-Relative Score
AFX.DE
Carl Zeiss Meditec AG
47
Peer-Score
Signal qualityHigh
vs
SOLV
Solventum Corporation
70
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: AFX.DE vs SOLV Profitability 35 74 Stability 24 58 Valuation 86 88 Growth 28 49 AFX.DE SOLV
Gap Ranking
#1 Profitability +39
#2 Stability +34
#3 Growth +21
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AFX.DE and SOLV Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AFX.DESOLV Relative valuation Structural strength

Solventum Corporation looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, Solventum Corporation ranks near the top of the group; Carl Zeiss Meditec AG sits in the weaker half.
Stability
On stability, Solventum Corporation is positioned higher in the group, while Carl Zeiss Meditec AG is closer to the middle.
Profitability — Dominant Gap
AFX.DE
35
SOLV
74
Gap+39in favour of SOLV

The profitability lead is mainly driven by a 7.1-point operating margin advantage.

What keeps the gap from being one-sided

Carl Zeiss Meditec AG still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both profitability and stability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the AFX.DE vs SOLV comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-stability comparisons

Explore how AFX.DE and SOLV each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.